Gene · 3598
Papers2,877
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
521 to 540 of 2,877
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Injectable, Drug-Eluting Nanocrystals Prevent Fibrosis and Stricture Formation In Vivo. | Gastroenterology | 2023 | 36657529 | PubTator, text mining | PubMed |
| Dysphagia Days as an Assessment of Clinical Treatment Outcome in Eosinophilic Esophagitis. | Am J Gastroenterol | 2023 | 36647838 | PubTator, text mining | PubMed |
| Keratinocytes activated by IL-4/IL-13 express IL-2Rγ with consequences on epidermal barrier function. | Exp Dermatol | 2023 | 36645024 | PubTator, text mining | PubMed |
| Interleukin-13 and its receptor are synaptic proteins involved in plasticity and neuroprotection. | Nat Commun | 2023 | 36639371 | PubTator, text mining | PubMed |
| Breast cancer heterogeneity and its implication in personalized precision therapy. | Exp Hematol Oncol | 2023 | 36624542 | PubTator, text mining | PubMed |
| Evidence that oncostatin M synergizes with IL-4 signaling to induce TSLP expression in chronic rhinosinusitis with nasal polyps. | J Allergy Clin Immunol | 2023 | 36623776 | PubTator, text mining | PubMed |
| Safety and antitumor activity of GD2-Specific 4SCAR-T cells in patients with glioblastoma. | Mol Cancer | 2023 | 36617554 | PubTator, text mining | PubMed |
| Activated T cell therapy targeting glioblastoma cancer stem cells. | Sci Rep | 2023 | 36604465 | PubTator, text mining | PubMed |
| Identification of glioblastoma-specific antigens expressed in patient-derived tumor cells as candidate targets for chimeric antigen receptor T cell therapy. | Neurooncol Adv | 2023 | 36601313 | PubTator, text mining | PubMed |
| Signaling pathways in brain tumors and therapeutic interventions. | Signal Transduct Target Ther | 2023 | 36596785 | PubTator, text mining | PubMed |
| Advanced T and Natural Killer Cell Therapy for Glioblastoma. | J Korean Neurosurg Soc | 2023 | 36588388 | PubTator, text mining | PubMed |
| Exploring genetic and immune underpinnings of the sexual dimorphism in tumor response to immune checkpoints inhibitors: A narrative review. | Curr Res Pharmacol Drug Discov | 2023 | 36571078 | PubTator, text mining | PubMed |
| Comprehensive clinical evaluation of CAR-T cell immunotherapy for solid tumors: a path moving forward or a dead end? | J Cancer Res Clin Oncol | 2023 | 36564524 | PubTator, text mining | PubMed |
| Immunotherapy for Pediatric Brain and Spine Tumors: Current State and Future Directions. | Pediatr Neurosurg | 2023 | 36549282 | PubTator, text mining | PubMed |
| COVID-19 plasma proteome reveals novel temporal and cell-specific signatures for disease severity and high-precision disease management. | J Cell Mol Med | 2023 | 36537107 | PubTator, text mining | PubMed |
| Current studies and future directions for medulloblastoma: A review from the pacific pediatric neuro-oncology consortium (PNOC) disease working group. | Neoplasia | 2023 | 36516489 | PubTator, text mining | PubMed |
| Dendritic cell vaccines improve the glioma microenvironment: Influence, challenges, and future directions. | Cancer Med | 2023 | 36464889 | PubTator, text mining | PubMed |
| Overcoming on-target, off-tumour toxicity of CAR T cell therapy for solid tumours. | Nat Rev Clin Oncol | 2023 | 36418477 | PubTator, text mining | PubMed |
| Cellular Cancer Immunotherapy Development and Manufacturing in the Clinic. | Clin Cancer Res | 2023 | 36383184 | PubTator, text mining | PubMed |
| First bioelectronic immunoplatform for quantitative secretomic analysis of total and metastasis-driven glycosylated haptoglobin. | Anal Bioanal Chem | 2023 | 36344668 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3598/papers?page=27